CTRI/2021/03/031634
Completed
未知
utritional therapy for cancer clients - Non randomized interventional trial
Rajiv Gandhi university of Health Sciences Grant in aid for advanced research project0 sites100 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Sponsor
- Rajiv Gandhi university of Health Sciences Grant in aid for advanced research project
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •those who are able to respond
- •not confined to bed
- •can understand and respond in English, kannada,tulu, hindi, malayalum
Exclusion Criteria
- •those who are critically ill
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Towards patient tailored cancer treatment supported by molecular imaging IMPACT: IMaging PAtients for Cancer drug selecTion - Metastatic Breast Cancermammacarcinomametastatic breast cancer10006291NL-OMON41527niversitair Medisch Centrum Groningen200
Active, not recruiting
Not Applicable
Imaging patients for cancer drug selection - metastatic breast cancerMetastatic Breast CancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2013-000551-41-NLniversity Medical Center Groningen
Active, not recruiting
Phase 1
Improving treatment selection in patients with cancer using a personalized screening testColorectal cancer and non-small cell lung cancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2014-003811-13-NLAntoni van Leeuwenhoek - Netherlands Cancer Institute70
Terminated
Not Applicable
Improving access to psychological services for people with cancer: A randomised controlled trial of an interactive web-based intervention (CancerCope)ACTRN12613001026718Griffith University490
Completed
Not Applicable
Cancer Research Campaign trial for the treatment of women with early breast cancer: the role of local prophylactic radiotherapyBreastCancerISRCTN65764657Cancer Research UK (CRUK) (UK)